DEK modulates both expression and alternative splicing of cancer‑related genes
DEK is known to be a potential proto‑oncogene and is highly expressed in gastric cancer (GC); thus, DEK is considered to contribute to the malignant progression of GC. DEK is an RNA‑binding protein involved in transcription, DNA repair, and selection of splicing sites during mRNA processing; however...
Main Authors: | Liu, B. (Author), Sun, Y. (Author), Suo, J. (Author), Xing, Y. (Author), Zhang, Y. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
NLM (Medline)
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Anomalies d'épissage dans les leucémies aigues myéloblastiques : rôle de WT1 et de DEK et impact clinique
by: Mint Mohamed, Aminetou
Published: (2015) -
Tristetraprolin specifically regulates the expression and alternative splicing of immune response genes in HeLa cells
by: Yafang Tu, et al.
Published: (2019-05-01) -
KRT18 Modulates Alternative Splicing of Genes Involved in Proliferation and Apoptosis Processes in Both Gastric Cancer Cells and Clinical Samples
by: Biao Chen, et al.
Published: (2021-07-01) -
MiR-138-5p Inhibits the Proliferation of Gastric Cancer Cells by Targeting DEK
by: Zhang W, et al.
Published: (2020-09-01) -
Oncogenic Phenotypes Induced by Overexpression of the DEK Proto-oncogene
by: Matrka, Marie C.
Published: (2017)